<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 12 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 0-28424
---------------
CARDIOGENESIS CORPORATION
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
540 Oakmead Parkway, Sunnyvale, California 94086 (650) 328-8500
- --------------------------------------------------------------------------------
(Address, including zip code, and telephone number,
including area code, of registrant's principal executive offices)
Common Stock, $.001 par value
- --------------------------------------------------------------------------------
(Title of each class of securities covered by this Form)
None
- --------------------------------------------------------------------------------
(Titles of all other classes of securities for which a
duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s)
relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) [X] Rule 12h 3(b)(1)(i) [X]
Rule 12g4-(a)(1)(ii) [ ] Rule 12h 3(b)(1)(ii) [ ]
Rule 12g4-(a)(2)(i) [ ] Rule 12h 3(b)(2)(i) [ ]
Rule 12g4-(a)(2)(i) [ ] Rule 12h 3(b)(2)(ii) [ ]
Rule 15d-6 [ ]
Approximate number of holders of record as of the certification or
notice date: 1
---------
<PAGE> 2
Pursuant to the requirements of the Securities Exchange Act of 1934,
CardioGenesis Corporation has caused this certification/notice to be signed on
its behalf by the undersigned duly authorized person.
Date: March 17, 1999
By: /s/ Richard P. Powers
----------------------------------
Richard P. Powers
Exective Vice President of Finance
and Administration and Chief
Financial Officer
